Experiences with cerebrospinal fluid analysis in Dutch memory clinics

European Journal of Neurology

Volumn 18, Issue 7, 2011, Pages 1014-1016

  Spies, P E ^a,b   Slats, D ^a,b   Ramakers, I ^c   Verhey, F R J ^c   Olde Rikkert, M G M ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Cerebrospinal fluid analysis; Dementia; Guidelines; Memory clinics

Indexed keywords

ARTICLE; CEREBROSPINAL FLUID ANALYSIS; DIAGNOSTIC REASONING; HEADACHE; HEALTH SURVEY; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MEMORY CLINIC; NETHERLANDS; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ALZHEIMER DISEASE; BIOLOGICAL MARKERS; HUMANS; NETHERLANDS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES; SPINAL PUNCTURE;

EID: 79958834842     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.03222.x     Document Type: Article

References (6)

1. Jack CR Jr, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 2010; 9: 119-128.
2. Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007; 6: 734-746.
3. Slats D, Spies PE, Sjogren MJ, et al. CSF biomarker utilisation and ethical considerations of biomarker assisted diagnosis and research in dementia: perspectives from within the European Alzheimer's Disease Consortium (EADC). J Neurol Neurosurg Psychiatry 2010; 81: 124-125.
4. Peskind ER, Riekse R, Quinn JF, et al. Safety and acceptability of the research lumbar puncture. Alzheimer Dis Assoc Disord 2005; 19: 220-225.
5. Mattson N, Zetterberg H, Hansson O, et al. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA 2009; 302: 385-393.
6. de Jong D, Kremer BP, Olde Rikkert MG, Verbeek MM. Current state and future directions of neurochemical biomarkers for Alzheimer's disease. Clin Chem Lab Med 2007; 45: 1421-1434.